Holen Sie sich die Stockscreener-App
6.4208
2.75%
-0.1192
Finanzdaten der Cns Pharmaceuticals Inc-Aktie (CNSP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
44.45%
2.4094
|
4.3377 | 3.20 | 5.6289 | 2.5281 |
| Operating Income/Loss |
44.45%
-2.4094
|
-4.3377 | -3.20 | -5.6289 | -2.5281 |
| Nonoperating Income/Loss |
5.27%
0.0344
|
0.0363 | 0.0237 | 0.023 | -0.00262 |
| Income/Loss From Continuing Operations Before Tax |
44.79%
-2.375
|
-4.3013 | -3.1764 | -5.6059 | -2.5308 |
| Income/Loss From Continuing Operations After Tax |
44.79%
-2.375
|
-4.3013 | -3.1764 | -5.6059 | -2.5308 |
|
Net Income/Loss
|
44.79%
-2.375
|
-4.3013 | -3.1764 | -5.6059 | -2.5308 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
86.43%
0.3701
|
2.7266 | -7.1991 | 22.18 | 0.3766 |
| Diluted Average Shares |
86.43%
0.3701
|
2.7266 | -7.1991 | 22.18 | 0.3766 |
| Basic Earnings Per Share |
306.33%
-6.42
|
-1.58 | -37.33 | -0.25 | -6.72 |
| Diluted Earnings Per Share |
306.33%
-6.42
|
-1.58 | -37.33 | -0.25 | -6.72 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.88%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):